Savant Capital LLC Has $543,000 Stock Position in Astera Labs, Inc. $ALAB

Savant Capital LLC increased its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 115.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,267 shares of the company’s stock after acquiring an additional 1,751 shares during the period. Savant Capital LLC’s holdings in Astera Labs were worth $543,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in the business. Assetmark Inc. boosted its position in shares of Astera Labs by 374.1% during the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after buying an additional 101 shares during the last quarter. Hilltop National Bank raised its position in Astera Labs by 100.0% in the 4th quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after buying an additional 100 shares during the last quarter. Aventura Private Wealth LLC purchased a new stake in Astera Labs in the 4th quarter valued at $33,000. Wexford Capital LP bought a new position in Astera Labs during the 3rd quarter valued at $39,000. Finally, National Bank of Canada FI lifted its stake in Astera Labs by 159.0% during the 3rd quarter. National Bank of Canada FI now owns 202 shares of the company’s stock valued at $39,000 after acquiring an additional 124 shares in the last quarter. Institutional investors own 60.47% of the company’s stock.

Insider Buying and Selling at Astera Labs

In other news, CEO Jitendra Mohan sold 325,693 shares of the stock in a transaction that occurred on Friday, April 17th. The shares were sold at an average price of $172.14, for a total transaction of $56,064,793.02. Following the completion of the transaction, the chief executive officer directly owned 4,079,322 shares of the company’s stock, valued at $702,214,489.08. This represents a 7.39% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 21st. The stock was sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the sale, the chief operating officer owned 5,064,213 shares of the company’s stock, valued at approximately $1,470,141,033.90. The trade was a 7.32% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 2,298,757 shares of company stock worth $472,787,436 over the last three months. 10.40% of the stock is currently owned by insiders.

Analyst Ratings Changes

ALAB has been the subject of several recent analyst reports. Rothschild & Co Redburn initiated coverage on shares of Astera Labs in a research note on Friday, May 1st. They issued a “neutral” rating and a $153.00 target price for the company. Royal Bank Of Canada raised their price target on shares of Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a research report on Wednesday, May 6th. JPMorgan Chase & Co. boosted their price target on shares of Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a report on Wednesday, May 6th. Weiss Ratings raised shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, May 21st. Finally, Loop Capital assumed coverage on shares of Astera Labs in a research note on Thursday, March 5th. They issued a “buy” rating and a $250.00 price objective for the company. Twelve research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $233.75.

Astera Labs Price Performance

Shares of Astera Labs stock opened at $358.05 on Friday. The firm has a market cap of $61.37 billion, a PE ratio of 241.93, a P/E/G ratio of 4.81 and a beta of 3.95. Astera Labs, Inc. has a 1 year low of $84.78 and a 1 year high of $372.37. The stock has a fifty day moving average price of $209.01 and a 200-day moving average price of $170.57.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The company had revenue of $308.36 million during the quarter, compared to analyst estimates of $292.19 million. During the same quarter in the prior year, the business earned $0.33 earnings per share. The firm’s revenue for the quarter was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, equities analysts anticipate that Astera Labs, Inc. will post 1.84 EPS for the current fiscal year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.